SI1562613T1 - Sestavek, ki obsega NADH/NADPH - Google Patents
Sestavek, ki obsega NADH/NADPHInfo
- Publication number
- SI1562613T1 SI1562613T1 SI200331205T SI200331205T SI1562613T1 SI 1562613 T1 SI1562613 T1 SI 1562613T1 SI 200331205 T SI200331205 T SI 200331205T SI 200331205 T SI200331205 T SI 200331205T SI 1562613 T1 SI1562613 T1 SI 1562613T1
- Authority
- SI
- Slovenia
- Prior art keywords
- nadh
- nadph
- containing compound
- antioxidant
- redox potential
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0173402A AT502435B1 (de) | 2002-11-19 | 2002-11-19 | Pharmazeutische zusammensetzung umfassend ein wasserstoffübertragendes coenzym und chlorophyll |
PCT/AT2003/000346 WO2004045626A1 (de) | 2002-11-19 | 2003-11-19 | Zusammensetzung umfassend nadh/nadph |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1562613T1 true SI1562613T1 (sl) | 2008-08-31 |
Family
ID=32315086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200331205T SI1562613T1 (sl) | 2002-11-19 | 2003-11-19 | Sestavek, ki obsega NADH/NADPH |
Country Status (18)
Country | Link |
---|---|
US (1) | US7255813B2 (sl) |
EP (1) | EP1562613B1 (sl) |
JP (2) | JP2006512320A (sl) |
CN (1) | CN1713916A (sl) |
AT (2) | AT502435B1 (sl) |
AU (1) | AU2003287740A1 (sl) |
CA (1) | CA2503860C (sl) |
DE (1) | DE50309383D1 (sl) |
DK (1) | DK1562613T3 (sl) |
ES (1) | ES2302957T3 (sl) |
HR (1) | HRP20050573B1 (sl) |
NO (1) | NO333911B1 (sl) |
PL (1) | PL214006B1 (sl) |
PT (1) | PT1562613E (sl) |
RS (1) | RS51606B (sl) |
RU (1) | RU2338540C2 (sl) |
SI (1) | SI1562613T1 (sl) |
WO (1) | WO2004045626A1 (sl) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT502435B1 (de) * | 2002-11-19 | 2008-01-15 | Oekopharm Forschungs Und Entwi | Pharmazeutische zusammensetzung umfassend ein wasserstoffübertragendes coenzym und chlorophyll |
JP5843448B2 (ja) * | 2011-02-08 | 2016-01-13 | 新日本製薬 株式会社 | 緑茶抽出液の製造方法、食品の製造方法、飲料の製造方法、洗浄剤の製造方法及び抗菌剤の製造方法 |
JP6288757B2 (ja) * | 2013-08-23 | 2018-03-07 | 京都府公立大学法人 | 運動機能性向上剤 |
CN104306390A (zh) * | 2014-10-23 | 2015-01-28 | 苏州人本药业有限公司 | 还原型辅酶ⅱ的用途 |
JP6129395B1 (ja) * | 2016-10-29 | 2017-05-17 | 誠一 荒木 | ミトコンドリア活性化に起因した血管内皮細胞保護回復用還元型ビタミンb2製剤 |
WO2018148930A1 (zh) * | 2017-02-17 | 2018-08-23 | 纯菁生物科技(美国)有限公司 | Nadh或者fadh2在癌症病人的营养干预上的应用 |
CN107213159B (zh) * | 2017-06-05 | 2020-06-23 | 苏州人本药业有限公司 | Nadph在制备抗焦虑药物中的应用 |
CN107213160B (zh) * | 2017-06-06 | 2020-07-24 | 重庆纳德福实业集团有限公司 | Nadph在拮抗药物致线粒体毒性中的应用 |
CN109620863A (zh) * | 2018-12-19 | 2019-04-16 | 泓博元生命科技(深圳)有限公司 | 一种缓解抑郁症的组合物及其制备方法与应用 |
CN109432181A (zh) * | 2018-12-19 | 2019-03-08 | 泓博元生命科技(深圳)有限公司 | 缓解抑郁症的组合物及其制备方法与应用 |
CN110339179A (zh) * | 2019-05-29 | 2019-10-18 | 泓博元生命科技(深圳)有限公司 | 含nadh或nadph的软胶囊及其制备方法和应用 |
CN112384080A (zh) * | 2019-06-04 | 2021-02-19 | 邦泰合盛生物科技(深圳)有限公司 | 辅酶膳食营养补充剂及其制备方法和应用 |
CN110237089A (zh) * | 2019-06-19 | 2019-09-17 | 泓博元生命科技(深圳)有限公司 | Nadh和/或nmn防治男性勃起功能障碍的应用 |
EP4470392A1 (de) * | 2023-06-02 | 2024-12-04 | Nutropia Group GmbH | Nicht-therapeutische verwendung eines nadh-präparats in kombination mit sport |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3934369A (en) * | 1974-04-23 | 1976-01-27 | University Of Illinois Foundation | Vitro net bioxynthesis of chlorophyll and grana |
JPS59216824A (ja) * | 1983-05-24 | 1984-12-06 | Yoshiro Shimura | 健康増進剤 |
JPS60132987A (ja) * | 1983-12-22 | 1985-07-16 | Riken Vitamin Co Ltd | クロロフイル組成物 |
JPS60221749A (ja) * | 1984-04-18 | 1985-11-06 | Mitsubishi Electric Corp | 光記録媒体 |
JPS614798A (ja) * | 1984-06-19 | 1986-01-10 | 東亞合成株式会社 | 高度不飽和脂肪酸組成物 |
JPS63237584A (ja) * | 1987-03-26 | 1988-10-04 | Mitsubishi Electric Corp | 光応答性スイツチ素子 |
IL95393A0 (en) * | 1989-08-18 | 1991-06-30 | John Morris Co | Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing |
US5760206A (en) * | 1992-12-11 | 1998-06-02 | E. I. Du Pont De Nemours And Company | Nucleotide sequence of soybean stearoyl-ACP desaturase gene |
US5332727A (en) * | 1993-04-29 | 1994-07-26 | Birkmayer U.S.A. | Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
CA2167104A1 (en) * | 1995-01-17 | 1996-07-18 | Joerg G.D. Birkmayer | Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration |
US5777190A (en) * | 1997-05-29 | 1998-07-07 | Battelle Memorial Institute | Method of controlled reduction of nitroaromatics by enzymatic reaction with oxygen sensitive nitroreductase enzymes |
US6133227A (en) * | 1997-06-23 | 2000-10-17 | The Procter & Gamble Company | Enzymatic detergent compositions |
JPH11292737A (ja) * | 1998-02-16 | 1999-10-26 | Shiseido Co Ltd | 免疫賦活剤 |
US6124242A (en) * | 1998-06-26 | 2000-09-26 | Basf Aktiengesellschaft | Herbicidal compositions and processes based on ferrodoxin:NADP reductase inhibitors |
RU2143212C1 (ru) * | 1998-07-29 | 1999-12-27 | Общество с ограниченной ответственностью "Фитолон" | Биологически активная добавка |
JP2001061498A (ja) * | 1999-08-31 | 2001-03-13 | Oriental Yeast Co Ltd | 還元型補酵素溶液 |
IT1318565B1 (it) * | 2000-06-09 | 2003-08-27 | World Pharma Tech Ltd | Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e. |
AT502435B1 (de) * | 2002-11-19 | 2008-01-15 | Oekopharm Forschungs Und Entwi | Pharmazeutische zusammensetzung umfassend ein wasserstoffübertragendes coenzym und chlorophyll |
-
2002
- 2002-11-19 AT AT0173402A patent/AT502435B1/de not_active IP Right Cessation
-
2003
- 2003-11-19 CA CA2503860A patent/CA2503860C/en not_active Expired - Lifetime
- 2003-11-19 RS YU20050376A patent/RS51606B/sr unknown
- 2003-11-19 PT PT03779534T patent/PT1562613E/pt unknown
- 2003-11-19 EP EP03779534A patent/EP1562613B1/de not_active Expired - Lifetime
- 2003-11-19 US US10/535,330 patent/US7255813B2/en not_active Expired - Lifetime
- 2003-11-19 PL PL377022A patent/PL214006B1/pl unknown
- 2003-11-19 RU RU2005119190/15A patent/RU2338540C2/ru active IP Right Revival
- 2003-11-19 CN CNA2003801035544A patent/CN1713916A/zh active Pending
- 2003-11-19 AU AU2003287740A patent/AU2003287740A1/en not_active Abandoned
- 2003-11-19 WO PCT/AT2003/000346 patent/WO2004045626A1/de active IP Right Grant
- 2003-11-19 DK DK03779534T patent/DK1562613T3/da active
- 2003-11-19 AT AT03779534T patent/ATE388714T1/de active
- 2003-11-19 JP JP2004552258A patent/JP2006512320A/ja active Pending
- 2003-11-19 SI SI200331205T patent/SI1562613T1/sl unknown
- 2003-11-19 ES ES03779534T patent/ES2302957T3/es not_active Expired - Lifetime
- 2003-11-19 DE DE50309383T patent/DE50309383D1/de not_active Expired - Lifetime
-
2005
- 2005-06-10 NO NO20052839A patent/NO333911B1/no not_active IP Right Cessation
- 2005-06-17 HR HRP20050573AA patent/HRP20050573B1/hr not_active IP Right Cessation
-
2011
- 2011-02-25 JP JP2011039874A patent/JP2011144186A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2006512320A (ja) | 2006-04-13 |
HRP20050573B1 (hr) | 2013-10-11 |
DK1562613T3 (da) | 2008-07-14 |
ES2302957T3 (es) | 2008-08-01 |
NO20052839L (no) | 2005-06-10 |
HRP20050573A2 (en) | 2006-07-31 |
PT1562613E (pt) | 2008-06-06 |
JP2011144186A (ja) | 2011-07-28 |
ATE388714T1 (de) | 2008-03-15 |
CN1713916A (zh) | 2005-12-28 |
PL214006B1 (pl) | 2013-06-28 |
RS20050376A (en) | 2007-12-31 |
EP1562613A1 (de) | 2005-08-17 |
US7255813B2 (en) | 2007-08-14 |
AT502435B1 (de) | 2008-01-15 |
NO333911B1 (no) | 2013-10-21 |
RS51606B (sr) | 2011-08-31 |
AT502435A1 (de) | 2007-03-15 |
WO2004045626A1 (de) | 2004-06-03 |
EP1562613B1 (de) | 2008-03-12 |
PL377022A1 (pl) | 2006-01-23 |
CA2503860C (en) | 2011-09-13 |
CA2503860A1 (en) | 2004-06-03 |
US20060011891A1 (en) | 2006-01-19 |
RU2005119190A (ru) | 2005-11-20 |
DE50309383D1 (de) | 2008-04-24 |
AU2003287740A1 (en) | 2004-06-15 |
RU2338540C2 (ru) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20050573B1 (hr) | Sastavi koji sadržavaju nadh/nadph | |
MXPA03010909A (es) | Derivados de epotilona. | |
UA81624C2 (ru) | Тризамещённые гетероарилы и способ их получения и применение | |
AU8112101A (en) | Non-imidazole aryloxypiperidines | |
MXPA04008772A (es) | Composiciones de clorhidrato de naltrexona. | |
PL353910A1 (en) | Novel compounds 0 derivatives of alpha-amino acid, method of obtaining them and compositions containing such derivatives | |
BG106444A (en) | Benzodiazepin derivatives, the production and use thereof | |
HK1111168A1 (en) | A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS | |
HK1074059A1 (en) | Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives | |
PL1668001T3 (pl) | Podstawione heteroarylobenzofuranowe kwasy | |
HK1085675A1 (en) | Anticancer compounds | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
RS19504A (en) | Novel compounds and compositions as cathepsin inhibitors | |
AU2003264688A1 (en) | Steel hollow-head screw | |
MXPA06003345A (es) | Derivados de aminopiridina como inhibidores de la no-sintasa inducible. | |
PL367429A1 (en) | Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and derivatives and method for the production and use thereof | |
WO2004024077A3 (en) | Novel composition and methods for the treatment of psoriasis | |
HK1075663A1 (en) | Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a sb 2 /sb | |
UA81664C2 (ru) | Производные дифенилмочевины и их применение, как блокаторов хлоридных каналов | |
WO2003088915A3 (en) | Novel sodium channel blockers | |
MXPA04000876A (es) | Derivados de acido butirico. | |
PL353291A1 (en) | Novel compounds, method of obtaining them, their application as pigments and composition containing them | |
MEP56208A (en) | Caloporoside derivatives, methods for the production thereof and their use | |
WO2004028447A3 (en) | Novel compositions and methods for the treatment of psoriasis |